Utah Launches First AI-Only Acne Prescription Pilot
Utah has become the first US state to allow an AI system to examine patients and prescribe medication without direct human oversight. The pilot, run by startup Nolla Health, focuses exclusively on mild-to-moderate acne. It uses a phased approach, starting with physician review of the first 100 prescriptions before moving to fully automated prescribing with retrospective checks. The program is limited to topical treatments and costs $4.99 per month.
Key points
- Nolla Health’s app scans patients’ faces and collects medical history to generate an acne severity score.
- The AI recommends from a list of eight approved topical medications, avoiding oral pills or hormone therapies.
- The pilot runs in three phases: initial physician review, retrospective weekly review, and final monthly sampling.
- Utah’s Office of Artificial Intelligence Policy waived state laws requiring a licensed human prescriber for this specific pilot.
- The program is limited to one year, with potential for two renewals, and targets an estimated 5,500 to 11,000 annual acne patients in the state.
Background
This development follows earlier AI medical pilots in Utah, including a 2026 program allowing AI to renew certain prescriptions, which faced backlash from the Utah Medical Licensing Board. In September 2026, the American Medical Association’s CEO publicly debated the limits of AI in medical practice, arguing that AI should not autonomously practice medicine without meeting high standards. Broader discussions in late 2026 have focused on AI liability and the need for human oversight in healthcare systems.
How outlets are covering it
Outlets highlight different aspects of the pilot’s risks and safeguards. TechSpot and Gizmodo emphasize the novelty of AI replacing doctors, noting the limited scope to low-risk topical treatments. STAT reports that Utah regulators are requiring third-party audits of company claims in response to criticism. The Los Angeles Times notes that Nolla Health engaged with the Utah Medical Licensing Board before launch, leading to a third-party physician oversight role, unlike the earlier Doctronic pilot which sparked controversy. All sources agree that the program is narrowly scoped to acne and includes phased human review, but differ on whether this represents a safe step or a dangerous precedent for autonomous medical practice.
Why it matters
This pilot tests the legal and practical boundaries of AI in healthcare, potentially setting a precedent for future automation of routine medical tasks. It could reduce costs and wait times for minor conditions but raises concerns about patient safety, regulatory oversight, and the erosion of human clinical judgment. The outcome may influence how other states and federal agencies regulate AI in medicine.
What to watch
The pilot will run for one year, with potential renewals. Nolla Health aims to expand beyond acne to other conditions. Utah’s Office of Artificial Intelligence Policy will monitor the program’s outcomes and may adjust regulations based on performance and safety data. The Utah Medical Licensing Board will oversee the third-party physician reviews.
- Utah will become first state to let AI examine patients and prescribe medication without direct human oversight TechSpot
- Utah plows ahead with more health AI pilots for prescriptions, women’s health STAT
- Utah Pilots AI-Only Examination and Prescription Process for Certain Patients Gizmodo
- Nolla Health launches Utah pilot for AI acne prescriptions MobiHealthNews
- Utah allows AI startup to prescribe acne medication without a doctor’s direct oversight Los Angeles Times
Want the full story? Read the original reporting
Read on TechSpot